$119.93
1.78% yesterday
NYSE, Jun 13, 10:10 pm CET
ISIN
US8793691069
Symbol
TFX
Sector

Teleflex Incorporated Stock price

$119.93
-6.87 5.42% 1M
-60.21 33.42% 6M
-58.05 32.62% YTD
-89.37 42.70% 1Y
-239.92 66.67% 5Y
-11.06 8.44% 10Y
+60.68 102.41% 20Y
NYSE, Closing price Fri, Jun 13 2025
-2.17 1.78%
ISIN
US8793691069
Symbol
TFX
Sector

Key metrics

Market capitalization $5.30b
Enterprise Value $6.92b
P/E (TTM) P/E ratio 36.90
EV/FCF (TTM) EV/FCF 14.43
EV/Sales (TTM) EV/Sales 2.30
P/S ratio (TTM) P/S ratio 1.76
P/B ratio (TTM) P/B ratio 1.31
Dividend yield 1.13%
Last dividend (FY24) $1.36
Revenue growth (TTM) Revenue growth 0.29%
Revenue (TTM) Revenue $3.01b
EBIT (operating result TTM) EBIT $540.06m
Free Cash Flow (TTM) Free Cash Flow $479.84m
Cash position $284.12m
EPS (TTM) EPS $3.25
P/E forward 14.35
P/S forward 1.71
EV/Sales forward 2.23
Short interest 3.81%
Show more

Is Teleflex Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Teleflex Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Teleflex Incorporated forecast:

3x Buy
19%
12x Hold
75%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a Teleflex Incorporated forecast:

Buy
19%
Hold
75%
Sell
6%

Financial data from Teleflex Incorporated

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
3,010 3,010
0% 0%
100%
- Direct Costs 1,334 1,334
0% 0%
44%
1,676 1,676
0% 0%
56%
- Selling and Administrative Expenses 975 975
4% 4%
32%
- Research and Development Expense 161 161
7% 7%
5%
816 816
2% 2%
27%
- Depreciation and Amortization 276 276
11% 11%
9%
EBIT (Operating Income) EBIT 540 540
7% 7%
18%
Net Profit 149 149
49% 49%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Teleflex Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Teleflex Incorporated Stock News

Neutral
GlobeNewsWire
2 days ago
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs). This prospective cohort study included more than 6,670 patients from 12 Intensive care units in eight hospitals across In...
Neutral
GlobeNewsWire
3 days ago
Timed with National Men's Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men 1 —and encourages them to take control of their health.
Neutral
GlobeNewsWire
23 days ago
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.
More Teleflex Incorporated News

Company Profile

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.

Head office United States
CEO Liam Kelly
Employees 14,100
Founded 1943
Website www.teleflex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today